1. Home
  2. ATGL vs CMPX Comparison

ATGL vs CMPX Comparison

Compare ATGL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

N/A

Current Price

$5.30

Market Cap

241.3M

Sector

N/A

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$0.91

Market Cap

203.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATGL
CMPX
Founded
2017
2014
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.3M
203.5M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
ATGL
CMPX
Price
$5.30
$0.91
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
7.9K
★ 3.9M
Earning Date
01-27-2027
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.52
$1.08
52 Week High
$50.00
$6.88

Technical Indicators

Market Signals
Indicator
ATGL
CMPX
Relative Strength Index (RSI) 43.03 16.38
Support Level $4.52 N/A
Resistance Level $7.55 $2.08
Average True Range (ATR) 0.61 0.09
MACD 0.14 -0.07
Stochastic Oscillator 33.58 0.00

Price Performance

Historical Comparison
ATGL
CMPX

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: